Market Overview

FDA Accepts and Files U.S. Smokeless Tobacco Company's Modified Risk Tobacco Product Application

Share:

U.S. Smokeless Tobacco Company, the U.S. smokeless tobacco industry
leader, announced today that the U.S. Food and Drug Administration (FDA)
accepted and filed for substantive scientific review a Modified Risk
Tobacco Product application for its moist smokeless tobacco product
Copenhagen® Snuff Fine Cut.

The application requests FDA authorization to make one claim: "IF YOU
SMOKE CONSIDER THIS: Switching completely to this product from
cigarettes reduces risk of lung cancer."

"It's critical that smokers have accurate, non-misleading health
information about different tobacco products," said Joe Murillo, Senior
Vice President, Regulatory Affairs, Altria Client Services. "We filed
this application because we think adult smokers looking for potential
reduced risk alternatives to cigarettes should have accurate information
about the relative risks of Copenhagen Snuff."

The Agency will begin a substantive scientific review process, which
includes opportunities for public comment.

Altria's Profile

Altria's wholly-owned subsidiaries include Philip Morris USA Inc., U.S.
Smokeless Tobacco Company LLC, John Middleton Co., Sherman Group
Holdings, LLC and its subsidiaries, Nu Mark LLC, Ste. Michelle Wine
Estates Ltd. and Philip Morris Capital Corporation. Altria holds an
equity investment in Anheuser-Busch InBev SA/NV.

The brand portfolios of Altria's tobacco operating companies include Marlboro®,
Black & Mild®, Copenhagen®,
Skoal®, MarkTen® and
Green Smoke®. Ste. Michelle produces and
markets premium wines sold under various labels, including Chateau
Ste. Michelle
®, Columbia Crest®,
14 Hands® and Stag's Leap Wine Cellars,
and it imports and markets Antinori®, Champagne
Nicolas Feuillatte
, Torres®
and Villa Maria Estate products in
the United States. Trademarks and service marks related to Altria
referenced in this release are the property of Altria or its
subsidiaries or are used with permission. More information about Altria
is available at altria.com and on the Altria Investor app.

Take a closer look at Altria and its companies on altria.com.

Follow Altria on Twitter at @AltriaNews.

View Comments and Join the Discussion!